NIH funding cuts delayed a promising childhood brain cancer trial. Patients lost time they didn't have.

AI Summary

Funding cuts at the NIH delayed a clinical trial for children with DIPG, a fatal brain tumor with very limited treatment options. This delay highlights the critical consequences of federal research funding reductions on health outcomes for pediatric patients.

A delayed clinical trial underscores the stakes of federal research funding cuts for children with DIPG, a deadly brain tumor with few treatment options.